Clinical Trials Browser

Phase 3 × Cabergoline × 1 year × Clear all

NCT07463235 2026-03-13

SPARAGMOS

Phase 3 Recruiting

Hyperprolactinemia, Prolactinoma

NCT02288962 2025-06-08

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

Phase 3 Active not recruiting

Adenoma, Pituitary Neoplasms